Pages that link to "Q46382065"
Jump to navigation
Jump to search
The following pages link to Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis (Q46382065):
Displaying 50 items.
- Diverse roles of SIRT1 in cancer biology and lipid metabolism (Q26997827) (← links)
- Lysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulation (Q27021965) (← links)
- New and emerging HDAC inhibitors for cancer treatment (Q27022413) (← links)
- Tumour biomarkers: homeostasis as a novel prognostic indicator (Q28069898) (← links)
- The sirtuins promote Dishevelled-1 scaffolding of TIAM1, Rac activation and cell migration (Q28304550) (← links)
- Spiro[pyrrolidine-3, 3´-oxindole] as potent anti-breast cancer compounds: Their design, synthesis, biological evaluation and cellular target identification (Q28828506) (← links)
- Histone deacetylase 1 is required for exocrine pancreatic epithelial proliferation in development and cancer (Q30499964) (← links)
- A systems approach to clinical oncology: focus on breast cancer (Q33238889) (← links)
- Protein modifications as potential biomarkers in breast cancer. (Q33586407) (← links)
- Specific activity of class II histone deacetylases in human breast cancer cells (Q33606021) (← links)
- Cancer epigenetics: a brief review (Q33614190) (← links)
- Novel (64)Cu-Labeled CUDC-101 for in Vivo PET Imaging of Histone Deacetylases (Q33635942) (← links)
- Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients (Q33642213) (← links)
- Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma (Q33785710) (← links)
- Current limitations and future opportunities for epigenetic therapies. (Q34195077) (← links)
- Histone deacetylases and cancer. (Q34298745) (← links)
- Systematic analysis of time-series gene expression data on tumor cell-selective apoptotic responses to HDAC inhibitors (Q34413200) (← links)
- Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies? (Q34417159) (← links)
- Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation (Q34448240) (← links)
- Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humans (Q34488391) (← links)
- Negative transcriptional control of ERBB2 gene by MBP-1 and HDAC1: diagnostic implications in breast cancer (Q34591795) (← links)
- Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression (Q34693969) (← links)
- Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast (Q34779627) (← links)
- Rational Therapeutic Combinations with Histone Deacetylase Inhibitors for the Treatment of Cancer (Q35079955) (← links)
- An atlas of histone deacetylase expression in breast cancer: fluorescence methodology for comparative semi-quantitative analysis. (Q35747470) (← links)
- Histone deacetylase (HDAC)-1, -2, -4 and -6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival (Q35821733) (← links)
- The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinom (Q35950987) (← links)
- Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy (Q35975127) (← links)
- Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer (Q35998436) (← links)
- Histone deacetylase inhibitors through click chemistry (Q36232945) (← links)
- Immunoexpression of HDAC1, HDAC2, and HAT1 in actinic cheilitis and lip squamous cell carcinoma. (Q36256046) (← links)
- Epigenetics as a therapeutic target in breast cancer (Q36449057) (← links)
- Microarrays to identify new therapeutic strategies for cancer (Q36680069) (← links)
- Development of histone deacetylase inhibitors for cancer treatment (Q36788512) (← links)
- Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas (Q36840303) (← links)
- Overexpression of caspase 7 is ERα dependent to affect proliferation and cell growth in breast cancer cells by targeting p21(Cip). (Q36846714) (← links)
- Histone modifications as markers of cancer prognosis: a cellular view. (Q36860601) (← links)
- HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses (Q37073624) (← links)
- Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression (Q37102942) (← links)
- Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy (Q37141408) (← links)
- Genetic dissection of histone deacetylase requirement in tumor cells (Q37194816) (← links)
- Histone deacetylase enzyme silencing using shRNAs enhances radiosensitivity of SW579 thyroid cancer cells (Q37297635) (← links)
- Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications (Q37512907) (← links)
- Inhibition of store-operated Ca2+ entry counteracts the apoptosis of nasopharyngeal carcinoma cells induced by sodium butyrate (Q37700705) (← links)
- Emerging biomarkers in breast cancer care (Q37779305) (← links)
- Epigenetic Alterations as Cancer Diagnostic, Prognostic, and Predictive Biomarkers (Q37798947) (← links)
- Inhibitor of growth-4 mediates chromatin modification and has a suppressive effect on tumorigenesis and innate immunity (Q37942489) (← links)
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications (Q37962333) (← links)
- HDAC inhibitor-based therapies: can we interpret the code? (Q38058971) (← links)
- Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011 - 2013). (Q38176396) (← links)